Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects (Q43603019)

25 November 2017

Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

25 November 2017

0 references

1 reference

1 reference

1 reference

3

1 reference

25 November 2017

2

Giorgio Barbarini

1 reference

25 November 2017

Gianluca Iacobellis

1

1 reference

PubMed ID

24115757

25 November 2017

Giuseppe Barbaro

series ordinal

4

1 reference

PubMed ID

24115757

25 November 2017

language of work or name

1 reference

17 October 2013

1 reference

25 November 2017

1 reference

25 November 2017

22

1 reference

25 November 2017

332-336

1 reference

25 November 2017

2

1 reference

Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features

25 November 2017

1 reference

Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart.

21 January 2018

1 reference

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians

21 January 2018

1 reference

Epicardial fat and vascular risk: a narrative review

21 January 2018

1 reference

Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.

21 January 2018

1 reference

Epicardial adipose tissue, hepatic steatosis and obesity.

21 January 2018

1 reference

Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

21 January 2018

1 reference

Relation of echocardiographic epicardial fat thickness and myocardial fat.

21 January 2018

1 reference

Echocardiographic epicardial fat: a review of research and clinical applications

21 January 2018

1 reference

Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome

21 January 2018

1 reference

Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus

21 January 2018

1 reference

Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk

21 January 2018

1 reference

Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography.

21 January 2018

1 reference

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

21 January 2018

1 reference

Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey

21 January 2018

1 reference

Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography.

21 January 2018

1 reference

Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content.

21 January 2018

1 reference

Substantial changes in epicardial fat thickness after weight loss in severely obese subjects

21 January 2018

1 reference

Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus

21 January 2018

1 reference

Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone

21 January 2018

1 reference

Myocardial Triglyceride Content and Epicardial Fat Mass in Human Obesity: Relationship to Left Ventricular Function and Serum Free Fatty Acid Levels

21 January 2018

1 reference

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20624

1 reference

25 November 2017

1 reference

PubMed ID

24115757